Shares of Sonova Holding (OTCMKTS:SONVY - Get Free Report) have earned an average rating of "Reduce" from the nine brokerages that are presently covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has assigned a strong buy recommendation to the company.
SONVY has been the topic of several analyst reports. Kepler Capital Markets upgraded Sonova from a "strong sell" rating to a "hold" rating in a research note on Friday, June 6th. Barclays lowered shares of Sonova from a "hold" rating to a "strong sell" rating in a research report on Friday, June 20th. Sanford C. Bernstein upgraded shares of Sonova from a "hold" rating to a "strong-buy" rating in a research report on Friday, July 18th. HSBC downgraded shares of Sonova from a "buy" rating to a "hold" rating in a report on Wednesday, May 21st. Finally, BNP Paribas cut shares of Sonova from a "strong-buy" rating to a "strong sell" rating in a report on Wednesday, June 11th.
View Our Latest Research Report on Sonova
Sonova Trading Down 0.5%
Shares of SONVY stock opened at $54.59 on Thursday. The stock's 50-day moving average price is $59.30 and its 200 day moving average price is $61.62. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.96 and a current ratio of 1.27. Sonova has a 52-week low of $52.83 and a 52-week high of $77.56.
Sonova Increases Dividend
The business also recently declared a dividend, which was paid on Wednesday, July 2nd. Stockholders of record on Tuesday, June 17th were paid a dividend of $0.6243 per share. This is a boost from Sonova's previous dividend of $0.57. The ex-dividend date of this dividend was Monday, June 16th. This represents a dividend yield of 99.0%.
Sonova Company Profile
(
Get Free Report)
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider SONOVA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SONOVA wasn't on the list.
While SONOVA currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.